Nephrology Doctors in Maine Medicare Details, Address, Contact
45 Nephrology doctors found. Showing 41 - 45
 Barbara Oberg-higgins, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6 Glen Cove Drive, Rockport, Rockport, ME 04856 Phone: 843-706-9955 Fax: 843-706-9956 |
Dr. Suzanne Humphries, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 435 Muzzy Ridge Rd, Searsmont, ME 04973 Phone: 207-342-2688 |
 Charles N Jacobs, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 149 North St, Waterville, ME 04901 Phone: 207-872-1293 Fax: 207-872-1091 |
Timothy Hendrickson, DO Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 149 North St, Mgha Hospitalist Program, Waterville, ME 04901 Phone: 207-626-1018 Fax: 207-872-1214 |
Catherine Stehman-breen, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5 Meetinghouse Ln, York, ME 03909 Phone: 207-361-4566 |
News Archive
VitalHealth announces latest version of EHR solution for small practices
VitalHealth Software, a leading provider of web-based software solutions for health management, today announced the beta testing availability of VitalHealth EHR for Practices version 1.8, the latest version of its electronic health record solution for small practices.
Stark racial disparities persist in vaccinations, state-level CDC data shows
Black Americans' covid-19 vaccination rates are still lagging months into the nation's campaign, while Hispanics are closing the gap and Native Americans show the highest rates overall, according to federal data obtained by KHN.
Food security and development lessons from Vietnam
In a post on the Guardian's "Poverty Matters Blog," Kenneth Quinn, president of the World Food Prize, discusses the impact of witnessing how road development influenced the introduction of "miracle rice" in Vietnam.
Phase 2 clinical study of PEG-Interferon lambda commenced
ZymoGenetics, Inc. today announced the initiation of a Phase 2 clinical trial of PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chronic hepatitis C virus (HCV) infection (the "EMERGE" study).
Bayer HealthCare to present results on investigational oncology compounds at ASCO annual meeting
Bayer HealthCare Pharmaceuticals, Inc. announced today that data evaluating several of its investigational oncology compounds will be presented in a scientific forum at the 2011 Annual Meeting of the American Society of Clinical Oncology, June 3-7, in Chicago, IL.
› Verified 9 days ago